Technical Analysis for ALXO - ALX Oncology Holdings Inc.

Grade Last Price % Change Price Change
D 83.33 0.39% 0.32
ALXO closed up 0.39 percent on Friday, January 15, 2021, on 56 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Up Down
Historical ALXO trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
NR7 Range Contraction 0.39%
Fell Below 20 DMA Bearish 1.41%
Multiple of Ten Bullish Other 1.41%
Lower Bollinger Band Touch Weakness 1.41%
20 DMA Support Bullish -3.33%
NR7 Range Contraction -3.33%
Crossed Above 20 DMA Bullish -3.07%
Older End-of-Day Signals for ALXO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic used for the treatment of myelodysplastic syndromes and acute myeloid leukemia, as well as a range of solid tumor indications, including head and neck squamous cell and human epidermal growth factor receptor 2 positive gastric/gastroesophageal junction carcinoma. The company was founded in 2015 and is based in Burlingame, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Clinical Medicine Oncology Cancer Immunotherapy Acute Myeloid Leukemia Carcinoma Epidermal Growth Factor Receptor Myelodysplastic Syndrome Syndromes Solid Tumor Myelodysplastic Syndromes CD47 Treatment Of Myelodysplastic Syndrome

Is ALXO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 117.45
52 Week Low 28.01
Average Volume 199,273
200-Day Moving Average 0.00
50-Day Moving Average 75.19
20-Day Moving Average 85.76
10-Day Moving Average 84.47
Average True Range 7.34
ADX 43.96
+DI 25.96
-DI 17.21
Chandelier Exit (Long, 3 ATRs ) 75.13
Chandelier Exit (Short, 3 ATRs ) 99.21
Upper Bollinger Band 91.67
Lower Bollinger Band 79.86
Percent B (%b) 0.29
BandWidth 13.77
MACD Line 2.07
MACD Signal Line 3.36
MACD Histogram -1.2925
Fundamentals Value
Market Cap 3.09 Billion
Num Shares 37.1 Million
EPS -0.74
Price-to-Earnings (P/E) Ratio -113.14
Price-to-Sales 1061.48
Price-to-Book 10.09
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 88.73
Resistance 3 (R3) 88.68 86.83 87.83
Resistance 2 (R2) 86.83 85.45 86.86 87.53
Resistance 1 (R1) 85.08 84.61 85.96 85.13 87.23
Pivot Point 83.23 83.23 83.67 83.26 83.23
Support 1 (S1) 81.48 81.85 82.36 81.53 79.43
Support 2 (S2) 79.63 81.01 79.66 79.13
Support 3 (S3) 77.88 79.63 78.83
Support 4 (S4) 77.93